Heart Failure

noreply@blogger.com (Jon Brassey) — Thu, 03 May 2007 06:53:00 +0000

This review is a pragmatic attempt to highlight recent research and some backround reading on heart failure. It should not be considered exhaustive, simply a way of reviewing some of the major developments and current thinking in the area.

Click here to see all the TRIP Evidence Reviews.

Evidence-Based Reports

Heart Failure. Clinical Evidence Concise, 2005
The Importance of Palliative Care in Heart Failure. NLH Specialist Library for CVD, 2007
A telephone intervention reduced combined all cause mortality or admission for worsening heart failure in chronic heart failure. Evidence-Based Nursing (Requires free registration), 2006
Does digoxin decrease morbidity for those in sinus rhythm with heart failure? Family Practice Inquiries Network, 2005
Does the long-term addition of the angiotensin-receptor blocker valsartan to standard therapy for heart failure patients reduce morbidity and mortality? NeLM CAT
A clinical prediction model predicted 30 day and 1 year mortality in patients admitted to hospital for heart failure. Evidence-Based Medicine (Requires free registration), 2005
A centralised telephone intervention reduced combined all cause mortality or admission for worsening HF in chronic heart failure. Evidence-Based Medicine (Requires free registration), 2006
A stepwise approach to managing heart failure. National Prescribing Service Limited, 2004

Clinical Guidelines

Evaluation and therapy for heart failure in the setting of ischemic heart disease: HFSA 2006 comprehensive heart failure practice guideline. Heart Failure Society of America, 2006
Surgical approaches to the treatment of heart failure: HFSA 2006 comprehensive heart failure practice guideline. Heart Failure Society of America, 2006
Evaluation and management of patients with heart failure and preserved left ventricular ejection fraction: HFSA 2006 comprehensive heart failure practice guideline. Heart Failure Society of America, 2006
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management
Heart failure in adults. Institute for Clinical Systems Improvement, 2006
Chronic heart failure: Management of chronic heart failure in adults in primary and secondary care. NICE, 2003
Management of chronic heart failure. SIGN, 2007
Heart Failure. PRODIGY, 2006

Systematic Reviews

Heart Failure, Testing for BNP and NT-proBNP. Agency for Healthcare Research and Quality - Evidence-based Practice, 2006
The use of B-type natriuretic peptides in the investigation of patients with suspected heart failure. NHS Quality Improvement Scotland, 2005
Diuretics for heart failure. Cochrane Database of Systematic Reviews, 2005
Cardiac resynchronisation therapy for severe heart failure. Medical Services Advisory Committee, 2006
Complexity of program and clinical outcomes of heart failure disease management incorporating specialist nurse-led heart failure clinics: a meta-regression analysis. DARE, 2005
Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database of Systematic Reviews, 2005
Clinical service organisation for heart failure. Cochrane Database of Systematic Reviews, 2005
Pentoxifylline for heart failure: a systematic review. DARE, 2005
Does this dyspneic patient in the emergency department have congestive heart failure? DARE, 2005
External counterpulsation for treatment of chronic stable angina pectoris and chronic heart failure. HTA, 2006
Non-compliance in patients with heart failure: how can we manage it? DARE, 2005
Multidisciplinary and multisetting team management programme in heart failure patients affects hospitalisation and costing. NHS EED
Prophylactic pacemaker use to allow beta-blocker therapy in patients with chronic heart failure with bradycardia. NHS EED, 2006

Recent articles in core journals

Angiotensin II Receptor Blockers for the Treatment of Heart Failure: A Class Effect? Pharmacotherapy, 2007
Association of parental heart failure with risk of heart failure in offspring. NEJM, 2006
The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation, 2006
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure. Eur Heart J, 2006
A novel prognostic index to determine the impact of cardiac conditions and co-morbidities on one-year outcome in patients with heart failure. Am J Cardiol, 2006
Automated review of electronic health records to assess quality of care for outpatients with heart failure. Annals of Internal Medicine, 2007
Computer-based education for patients with chronic heart failure A randomised, controlled, multicentre trial of the effects on knowledge, compliance and quality of life. Patient Educ Couns, 2006
Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA, 2007
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA, 2007
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA, 2007
Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis. Eur Heart J, 2007
Carvedilol Protects Better Against Vascular Events Than Metoprolol in Heart Failure Results From COMET. J Am Coll Cardiol, 2007
Trends in prevalence and outcome of heart failure with preserved ejection fraction. NEJM, 2006
Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation, 2006

eTextbooks

Clinical Queries

Do you have a summary of the major evidence regarding ACE Inhibitors and Angiotensin 2 antagonists in heart failure? NLH Q&A Service, 2007
Is a BNP blood test a good screening test for identifying heart failure and is it cost effective? NLH Q&A Service, 2006 View answer OR Can you answer this question for extra CPD?
Is there any evidence to support adding an angiotensin II receptor antagonist blocker to an ACE-inhibitor in heart failure? NLH Q&A Service, 2006
What exactly are the mechanisms through which low dose beta-blockers act to give benefit in heart failure? NLH Q&A Service, 2006 View answer OR Can you answer this question for extra CPD?
When would you use oxygen in a patient diagnosed with heart failure? Are there any contraindications? NLH Q&A Service, 2006 View answer OR Can you answer this question for extra CPD?

Patient Information

TRIP Evidence Reviews: Heart Failure

Heart Failure